Skip to main content
SpringerLink
Log in

Atypical Teratoid/Rhabdoid Tumor (AT/RT)

  • Chapter
  • First Online:
Pediatric Radiation Oncology

Part of the book series: Pediatric Oncology ((PEDIATRICO))

Abstract

Atypical Teratoid/Rhabdoid Tumor (AT/RT) is a rare and aggressive tumor of the Pediatric Central Nervous System (CNS) that was first described in 1987 (Biggs et al. 1987). Its aggressive behavior and predilection for infants who are less than 2 years of age enticed further study and pathological characterization over the 1990s (Burger et al. 1998; Rorke et al. 1996b). AT/RT histopathology is characterized by complex rhabdoid, epithelial, and mesenchymal cellular morphology and is genetically defined by loss of SMARCB1. Despite this early observation, AT/RT remains a challenging disease, with high mortality rates despite aggressive multimodality therapy including surgery, various chemotherapy regimens with or without stem cell transplant, intrathecal chemotherapy, and radiotherapy. The challenge is due in part to the very young age of presentation for most patients which can limit aggressive treatment particularly radiotherapy, as well as the relatively high rate of disseminated disease at diagnosis. Retrospective series, reported across multiple institutions, helped guide the development of a Children Oncology Group (COG) study designed for AT/RT (ACNS0333) that closed for accrual in February 2014. This was the first cooperative group prospective study dedicated for ATRT patients in an attempt to standardize the approach to treat AT/RT based on best available data from previous published experiences This chapter discusses the epidemiology of AT/RT, clinical features and evaluation, pathology and genetic abnormalities, and current treatment approaches. In addition, experimental therapies under investigation, as well as salvage treatment options, are reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Alarcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV (2006) Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. Oncogene 25:722–734

    Article  CAS  PubMed  Google Scholar 

  • Arcaro A, Doepfner KT, Boller D, Guerreiro AS, Shalaby T, Jackson SP, Schoenwaelder SM, Delattre O, Grotzer MA, Fischer B (2007) Novel role for insulin as an autocrine growth factor for malignant brain tumour cells. Biochem J 406:57–66

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Athale UH, Duckworth J, Odame I, Barr R (2009) Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies. J Pediatr Hematol Oncol 31:651–663

    Article  PubMed  Google Scholar 

  • Au Yong KJ, Jaremko JL, Jans L, Bhargava R, Coleman LT, Mehta V, Ditchfield MR (2013) How specific is the MRI appearance of supratentorial atypical teratoid rhabdoid tumors?. Pediatr Radiol 43(3):347–54 doi:10.1007/s00247-012-2530-z. Epub 2012 Nov 10. PMID is 23143401

  • Bailey CC, Gnekow A, Wellek S, Jones M, Round C, Brown J, Phillips A, Neidhardt MK (1995) Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 25:166–178

    Article  CAS  PubMed  Google Scholar 

  • Bambakidis NC, Robinson S, Cohen M, Cohen AR (2002) Atypical teratoid/rhabdoid tumors of the central nervous system: clinical, radiographic and pathologic features. Pediatr Neurosurg 37:64–70

    Article  PubMed  Google Scholar 

  • Beckwith JB, Palmer NF (1978) Histopathology and prognosis of Wilms tumors: results from the First National Wilms’ Tumor Study. Cancer 41:1937–1948

    Article  CAS  PubMed  Google Scholar 

  • Betz BL, Strobeck MW, Reisman DN, Knudsen ES, Weissman BE (2002) Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. Oncogene 21:5193–5203

    Article  CAS  PubMed  Google Scholar 

  • Biegel JA, Rorke LB, Emanuel BS (1989) Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain. N Engl J Med 321:906

    CAS  PubMed  Google Scholar 

  • Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74–79

    CAS  PubMed  Google Scholar 

  • Biggs PJ, Garen PD, Powers JM, Garvin AJ (1987) Malignant rhabdoid tumor of the central nervous system. Hum Pathol 18:332–337

    Article  CAS  PubMed  Google Scholar 

  • Bonnin JM, Rubinstein LJ, Palmer NF, Beckwith JB (1984) The association of embryonal tumors originating in the kidney and in the brain. A report of seven cases. Cancer 54:2137–2146

    Article  CAS  PubMed  Google Scholar 

  • Burger PC, Yu IT, Tihan T, Friedman HS, Strother DR, Kepner JL, Duffner PK, Kun LE, Perlman EJ (1998) Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. Am J Surg Pathol 22:1083–1092

    Article  CAS  PubMed  Google Scholar 

  • Buscariollo DL, Park HS, Roberts KB, Yu JB (2012) Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis. Cancer 118:4212–4219

    Article  PubMed  Google Scholar 

  • Chai B, Huang J, Cairns BR, Laurent BC (2005) Distinct roles for the RSC and Swi/Snf ATP-dependent chromatin remodelers in DNA double-strand break repair. Genes Dev 19:1656–1661

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen ML, Mccomb JG, Krieger MD (2005) Atypical teratoid/rhabdoid tumors of the central nervous system: management and outcomes. Neurosurg Focus 18:E8

    Article  PubMed  Google Scholar 

  • Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA, Rorke-Adams LB, Fisher MJ, Janss A, Mazewski C, Goldman S, Manley PE, Bowers DC, Bendel A, Rubin J, Turner CD, Marcus KJ, Goumnerova L, Ullrich NJ, Kieran MW (2009) Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 27:385–389

    Article  PubMed  PubMed Central  Google Scholar 

  • Chou SM, Anderson JS (1991) Primary CNS malignant rhabdoid tumor (MRT): report of two cases and review of literature. Clin Neuropathol 10:1–10

    CAS  PubMed  Google Scholar 

  • Chrzanowska EK, Bartoszewska J, Drogosiewicz M, Kwiatkowski S, Skowrońska-Gardas A (2009) The importance of radiotherapy in paediatric atypical teratoid rhabdoid tumour of the brain. Rep Pract Oncol Radiother 14:53–57

    Article  Google Scholar 

  • Cohen BH, Geyer JR, Miller DC, Curran JG, Zhou T, Holmes E, Ingles SA, Dunkel IJ, Hilden J, Packer RJ, Pollack IF, Gajjar A, Finlay JL (2015) Pilot study of intensive chemotherapy with peripheral hematopoietic cell support for children less than 3 years of age with malignant brain tumors, the CCG-99703 phase I/II study. A report from the Children’s Oncology Group. Pediatr Neurol 53:31–46

    Article  PubMed  PubMed Central  Google Scholar 

  • De Amorim Bernstein K, Sethi R, Trofimov A, Zeng C, Fullerton B, Yeap BY, Ebb D, Tarbell NJ, Yock TI, Macdonald SM (2013) Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors. Int J Radiat Oncol Biol Phys 86:114–120

    Article  PubMed  Google Scholar 

  • Doan DN, Veal TM, Yan Z, Wang W, Jones SN, Imbalzano AN (2004) Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes. Oncogene 23:3462–3473

    Article  CAS  PubMed  Google Scholar 

  • Douglass EC, Valentine M, Rowe ST, Parham DM, Wilimas JA, Sanders JM, Houghton PJ (1990) Malignant rhabdoid tumor: a highly malignant childhood tumor with minimal karyotypic changes. Genes Chromosomes Cancer 2:210–216

    Article  CAS  PubMed  Google Scholar 

  • Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR et al (1993) Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328:1725–1731

    Article  CAS  PubMed  Google Scholar 

  • Eaton KW, Tooke LS, Wainwright LM, Judkins AR, Biegel JA (2011) Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 56:7–15

    Article  PubMed  PubMed Central  Google Scholar 

  • Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH, Aoki M, Hosono N, Kubo M, Miya F, Arai Y, Takahashi H, Shirakihara T, Nagasaki M, Shibuya T, Nakano K, Watanabe-Makino K, Tanaka H, Nakamura H, Kusuda J, Ojima H, Shimada K, Okusaka T, Ueno M, Shigekawa Y, Kawakami Y, Arihiro K, Ohdan H, Gotoh K, Ishikawa O, Ariizumi S, Yamamoto M, Yamada T, Chayama K, Kosuge T, Yamaue H, Kamatani N, Miyano S, Nakagama H, Nakamura Y, Tsunoda T, Shibata T, Nakagawa H (2012) Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 44:760–764

    Article  CAS  PubMed  Google Scholar 

  • Gardner SL, Asgharzadeh S, Green A, Horn B, Mccowage G, Finlay J (2008) Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatr Blood Cancer 51:235–240

    Article  PubMed  Google Scholar 

  • Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T (2005) Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children’s Cancer Group. J Clin Oncol 23:7621–7631

    Article  PubMed  Google Scholar 

  • Ginn KF, Gajjar A (2012) Atypical teratoid rhabdoid tumor: current therapy and future directions. Front Oncol 2:114

    Article  PubMed  PubMed Central  Google Scholar 

  • Hasselblatt M, Gesk S, Oyen F, Rossi S, Viscardi E, Giangaspero F, Giannini C, Judkins AR, Fruhwald MC, Obser T, Schneppenheim R, Siebert R, Paulus W (2011) Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Am J Surg Pathol 35:933–935

    Article  PubMed  Google Scholar 

  • Hasselblatt M, Isken S, Linge A, Eikmeier K, Jeibmann A, Oyen F, Nagel I, Richter J, Bartelheim K, Kordes U, Schneppenheim R, Fruhwald M, Siebert R, Paulus W (2013) High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors. Genes Chromosomes Cancer 52:185–190

    Article  CAS  PubMed  Google Scholar 

  • Hilden JM, Meerbaum S, Burger P, Finlay J, Janss A, Scheithauer BW, Walter AW, Rorke LB, Biegel JA (2004) Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol 22:2877–2884

    Article  PubMed  Google Scholar 

  • Hirth A, Pedersen PH, Wester K, Mork S, Helgestad J (2003) Cerebral atypical teratoid/rhabdoid tumor of infancy: long-term survival after multimodal treatment, also including triple intrathecal chemotherapy and gamma knife radiosurgery—case report. Pediatr Hematol Oncol 20:327–332

    Article  CAS  PubMed  Google Scholar 

  • Jagani Z, Mora-Blanco EL, Sansam CG, Mckenna ES, Wilson B, Chen D, Klekota J, Tamayo P, Nguyen PT, Tolstorukov M, Park PJ, Cho YJ, Hsiao K, Buonamici S, Pomeroy SL, Mesirov JP, Ruffner H, Bouwmeester T, Luchansky SJ, Murtie J, Kelleher JF, Warmuth M, Sellers WR, Roberts CW, Dorsch M (2010) Loss of the tumor suppressor SNF5 leads to aberrant activation of the Hedgehog-GLI pathway. Nat Med 16:1429–1433

    Article  CAS  PubMed  Google Scholar 

  • Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA (2004) Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 28:644–650

    Article  PubMed  Google Scholar 

  • Kaderali Z, Lamberti-Pasculli M, Rutka JT (2009) The changing epidemiology of paediatric brain tumours: a review from the Hospital for Sick Children. Childs Nerv Syst 25:787–793

    Article  PubMed  Google Scholar 

  • Kerstiens J, Johnstone PA (2014) Proton therapy expansion under current United States reimbursement models. Int J Radiat Oncol Biol Phys 89:235–240

    Article  PubMed  Google Scholar 

  • Kim KH, Roberts CW (2014) Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth. Cancer Genet 207:365–372

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3:255–268

    Article  CAS  PubMed  Google Scholar 

  • Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225; discussion 226-9

    Article  PubMed  Google Scholar 

  • Knutson SK, Warholic NM, Wigle TJ, Klaus CR, Allain CJ, Raimondi A, Porter Scott M, Chesworth R, Moyer MP, Copeland RA, Richon VM, Pollock RM, Kuntz KW, Keilhack H (2013) Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2. Proc Natl Acad Sci U S A 110:7922–7927

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kuwahara Y, Wei D, Durand J, Weissman BE (2013) SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters. Mol Cancer Res 11:251–260

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lafay-Cousin L, Fay-Mcclymont T, Johnston D, Fryer C, Scheinemann K, Fleming A, Hukin J, Janzen L, Guger S, Strother D, Mabbott D, Huang A, Bouffet E (2015) Neurocognitive evaluation of long term survivors of atypical teratoid rhabdoid tumors (ATRT): the Canadian registry experience. Pediatr Blood Cancer 62:1265–1269

    Article  PubMed  Google Scholar 

  • Lafay-Cousin L, Hawkins C, Carret AS, Johnston D, Zelcer S, Wilson B, Jabado N, Scheinemann K, Eisenstat D, Fryer C, Fleming A, Mpofu C, Larouche V, Strother D, Bouffet E, Huang A (2012) Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric Brain Tumour Consortium experience. Eur J Cancer 48:353–359

    Article  CAS  PubMed  Google Scholar 

  • Lee RS, Roberts CW (2013) Rhabdoid tumors: an initial clue to the role of chromatin remodeling in cancer. Brain Pathol 23:200–205

    Article  CAS  PubMed  Google Scholar 

  • Lee RS, Stewart C, Carter SL, Ambrogio L, Cibulskis K, Sougnez C, Lawrence MS, Auclair D, Mora J, Golub TR, Biegel JA, Getz G, Roberts CW (2012) A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J Clin Invest 122:2983–2988

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee S, Cimica V, Ramachandra N, Zagzag D, Kalpana GV (2011) Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival. Cancer Res 71:3225–3235

    Article  CAS  PubMed  Google Scholar 

  • Lo SS, Fakiris AJ, Abdulrahman R, Henderson MA, Chang EL, Suh JH, Timmerman RD (2008) Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy in pediatric brain tumors. Expert Rev Neurother 8:121–132

    Article  PubMed  Google Scholar 

  • Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109

    Article  PubMed  PubMed Central  Google Scholar 

  • Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C, Figarella-Branger D, Fuller GN, Giangaspero F, Giannini C, Hawkins C, Kleihues P, Korshunov A, Kros JM, Beatriz Lopes M, Ng HK, Ohgaki H, Paulus W, Pietsch T, Rosenblum M, Rushing E, Soylemezoglu F, Wiestler O, Wesseling P, International Society of Neuropathology—Haarlem (2014) International Society of Neuropathology—Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24:429–435

    Article  PubMed  Google Scholar 

  • Margol AS, Judkins AR (2014) Pathology and diagnosis of SMARCB1-deficient tumors. Cancer Genet 207:358–364

    Article  CAS  PubMed  Google Scholar 

  • Maris JM, Morton CL, Gorlick R, Kolb EA, Lock R, Carol H, Keir ST, Reynolds CP, Kang MH, Wu J, Smith MA, Houghton PJ (2010) Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP). Pediatr Blood Cancer 55:26–34

    PubMed  PubMed Central  Google Scholar 

  • Masliah-Planchon J, Bieche I, Guinebretiere JM, Bourdeaut F, Delattre O (2015) SWI/SNF chromatin remodeling and human malignancies. Annu Rev Pathol 10:145–171

    Article  CAS  PubMed  Google Scholar 

  • Mcgovern SL, Okcu MF, Munsell MF, Kumbalasseriyil N, Grosshans DR, Mcaleer MF, Chintagumpala M, Khatua S, Mahajan A (2014) Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system. Int J Radiat Oncol Biol Phys 90:1143–1152

    Article  PubMed  PubMed Central  Google Scholar 

  • Merchant TE, Hua CH, Shukla H, Ying X, Nill S, Oelfke U (2008) Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer 51:110–117

    Article  PubMed  Google Scholar 

  • Meyers SP, Khademian ZP, Biegel JA, Chuang SH, Korones DN, Zimmerman RA (2006) Primary intracranial atypical teratoid/rhabdoid tumors of infancy and childhood: MRI features and patient outcomes. AJNR Am J Neuroradiol 27:962–971

    CAS  PubMed  Google Scholar 

  • Mora-Blanco EL, Mishina Y, Tillman EJ, Cho YJ, Thom CS, Pomeroy SL, Shao W, Roberts CW (2014) Activation of beta-catenin/TCF targets following loss of the tumor suppressor SNF5. Oncogene 33:933–938

    Article  CAS  PubMed  Google Scholar 

  • Mosse YP, Lipsitz E, Fox E, Teachey DT, Maris JM, Weigel B, Adamson PC, Ingle MA, Ahern CH, Blaney SM (2012) Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children’s Oncology Group Phase I Consortium study. Clin Cancer Res 18:6058–6064

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nie Z, Xue Y, Yang D, Zhou S, Deroo BJ, Archer TK, Wang W (2000) A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol Cell Biol 20:8879–8888

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ogino S, Kubo S, Abdul-Karim FW, Cohen ML (2001) Comparative immunohistochemical study of insulin-like growth factor II and insulin-like growth factor receptor type 1 in pediatric brain tumors. Pediatr Dev Pathol 4:23–31

    Article  CAS  PubMed  Google Scholar 

  • Olson TA, Bayar E, Kosnik E, Hamoudi AB, Klopfenstein KJ, Pieters RS, Ruymann FB (1995) Successful treatment of disseminated central nervous system malignant rhabdoid tumor. J Pediatr Hematol Oncol 17:71–75

    Article  CAS  PubMed  Google Scholar 

  • Ostrom QT, Chen Y, M de Blank P, Ondracek A, Farah P, Gittleman H, Wolinsky Y, Kruchko C, Cohen ML, Brat DJ, Barnholtz-Sloan JS (2014) The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001–2010. Neuro-Oncology 16:1392–1399

    Article  PubMed  PubMed Central  Google Scholar 

  • Packer RJ, Biegel JA, Blaney S, Finlay J, Geyer JR, Heideman R, Hilden J, Janss AJ, Kun L, Vezina G, Rorke LB, Smith M (2002) Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Hematol Oncol 24:337–342

    Article  PubMed  Google Scholar 

  • Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, Muraszko K, Rorke LB, Wara WM, Cohen BH, Boyett JM (1999) Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children’s Cancer Group Study. J Clin Oncol 17:2127–2136

    Article  CAS  PubMed  Google Scholar 

  • Pai Panandiker AS, Merchant TE, Beltran C, Wu S, Sharma S, Boop FA, Jenkins JJ, Helton KJ, Wright KD, Broniscer A, Kun LE, Gajjar A (2012) Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system. Int J Radiat Oncol Biol Phys 82:1756–1763

    Article  PubMed  Google Scholar 

  • Parham DM, Weeks DA, Beckwith JB (1994) The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy. Am J Surg Pathol 18:1010–1029

    Article  CAS  PubMed  Google Scholar 

  • Patel S, Kostaras X, Parliament M, Olivotto IA, Nordal R, Aronyk K, Hagen N (2014) Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada? Curr Oncol 21:251–262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Radcliffe J, Bunin GR, Sutton LN, Goldwein JW, Phillips PC (1994) Cognitive deficits in long-term survivors of childhood medulloblastoma and other noncortical tumors: age-dependent effects of whole brain radiation. Int J Dev Neurosci 12:327–334

    Article  CAS  PubMed  Google Scholar 

  • Roberts CW, Galusha SA, Mcmenamin ME, Fletcher CD, Orkin SH (2000) Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc Natl Acad Sci U S A 97:13796–13800

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rorke LB (1987) Classification of central nervous system tumors in children. Prog Exp Tumor Res 30:57–60

    Article  CAS  PubMed  Google Scholar 

  • Rorke LB, Packer RJ, Biegel JA (1996a) Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56–65

    Article  CAS  PubMed  Google Scholar 

  • Rorke LB, Packer RJ, Biegel JA (1996b) Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56–65

    Article  CAS  PubMed  Google Scholar 

  • Sabin ND, Merchant TE, Harreld JH, Patay Z, Klimo P Jr, Qaddoumi I, Armstrong GT, Wright K, Gray J, Indelicato DJ, Gajjar A (2013) Imaging changes in very young children with brain tumors treated with proton therapy and chemotherapy. AJNR Am J Neuroradiol 34:446–450

    Article  CAS  PubMed  Google Scholar 

  • Schneppenheim R, Fruhwald MC, Gesk S, Hasselblatt M, Jeibmann A, Kordes U, Kreuz M, Leuschner I, Martin Subero JI, Obser T, Oyen F, Vater I, Siebert R (2010) Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet 86:279–284

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shao Z, Raible F, Mollaaghababa R, Guyon JR, Wu CT, Bender W, Kingston RE (1999) Stabilization of chromatin structure by PRC1, a Polycomb complex. Cell 98:37–46

    Article  CAS  PubMed  Google Scholar 

  • Sinha M, Watanabe S, Johnson A, Moazed D, Peterson CL (2009) Recombinational repair within heterochromatin requires ATP-dependent chromatin remodeling. Cell 138:1109–1121

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Slavc I, Chocholous M, Leiss U, Haberler C, Peyrl A, Azizi AA, Dieckmann K, Woehrer A, Peters C, Widhalm G, Dorfer C, Czech T (2014) Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992–2012. Cancer Med 3:91–100

    Article  PubMed  Google Scholar 

  • Squire SE, Chan MD, Marcus KJ (2007) Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy. J Neuro-Oncol 81:97–111

    Article  Google Scholar 

  • Stephens PJ, Tarpey PS, Davies H, van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, Yates LR, Papaemmanuil E, Beare D, Butler A, Cheverton A, Gamble J, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, Lau KW, Mclaren S, Mcbride DJ, Menzies A, Mudie L, Raine K, Rad R, Chapman MS, Teague J, Easton D, Langerod A, Oslo Breast Cancer C, Lee MT, Shen CY, Tee BT, Huimin BW, Broeks A, Vargas AC, Turashvili G, Martens J, Fatima A, Miron P, Chin SF, Thomas G, Boyault S, Mariani O, Lakhani SR, van de Vijver M, Van ‘t Veer L, Foekens J, Desmedt C, Sotiriou C, Tutt A, Caldas C, Reis-Filho JS, Aparicio SA, Salomon AV, Borresen-Dale AL, Richardson AL, Campbell PJ, Futreal PA, Stratton MR (2012) The landscape of cancer genes and mutational processes in breast cancer. Nature 486:400–404

    CAS  PubMed  PubMed Central  Google Scholar 

  • Strother D, Linda S, Burger P, Aronin P, Constine L, Langston J, Duffner P, Friedman H, Kupst M, Kun L (2004) Outcome of therapy for atypical teratoid/rhabdoid tumors (ATRT) on Pediatric Oncology Group study (POG) 9233/34. Neuro-Oncology 6:466

    Google Scholar 

  • Taylor MD, Gokgoz N, Andrulis IL, Mainprize TG, Drake JM, Rutka JT (2000) Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. Am J Hum Genet 66:1403–1406

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, Krasin M, Dalton J, Hale G, Kun LE, Wallace D, Gilbertson RJ, Gajjar A (2005) Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 23:1491–1499

    Article  CAS  PubMed  Google Scholar 

  • Thomas PR, Deutsch M, Kepner JL, Boyett JM, Krischer J, Aronin P, Albright L, Allen JC, Packer RJ, Linggood R, Mulhern R, Stehbens JA, Langston J, Stanley P, Duffner P, Rorke L, Cherlow J, Friedman HS, Finlay JL, Vietti TJ, Kun LE (2000) Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 18:3004–3011

    Article  CAS  PubMed  Google Scholar 

  • Torchia J, Picard D, Lafay-Cousin L, Hawkins CE, Kim SK, Letourneau L, Ra YS, Ho KC, Chan TS, Sin-Chan P, Dunham CP, Yip S, Ng HK, Lu JQ, Albrecht S, Pimentel J, Chan JA, Somers GR, Zielenska M, Faria CC, Roque L, Baskin B, Birks D, Foreman N, Strother D, Klekner A, Garami M, Hauser P, Hortobagyi T, Bognar L, Wilson B, Hukin J, Carret AS, van Meter TE, Nakamura H, Toledano H, Fried I, Fults D, Wataya T, Fryer C, Eisenstat DD, Scheineman K, Johnston D, Michaud J, Zelcer S, Hammond R, Ramsay DA, Fleming AJ, Lulla RR, Fangusaro JR, Sirachainan N, Larbcharoensub N, Hongeng S, Barakzai MA, Montpetit A, Stephens D, Grundy RG, Schuller U, Nicolaides T, Tihan T, Phillips J, Taylor MD, Rutka JT, Dirks P, Bader GD, Warmuth-Metz M, Rutkowski S, Pietsch T, Judkins AR, Jabado N, Bouffet E, Huang A (2015) Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis. Lancet Oncol 16:569–582

    Article  CAS  PubMed  Google Scholar 

  • Tsikitis M, Zhang Z, Edelman W, Zagzag D, Kalpana GV (2005) Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss. Proc Natl Acad Sci U S A 102:12129–12134

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tsuneyoshi M, Daimaru Y, Hashimoto H, Enjoji M (1985) Malignant soft tissue neoplasms with the histologic features of renal rhabdoid tumors: an ultrastructural and immunohistochemical study. Hum Pathol 16:1235–1242

    Article  CAS  PubMed  Google Scholar 

  • Venneti S, Le P, Martinez D, Eaton KW, Shyam N, Jordan-Sciutto KL, Pawel B, Biegel JA, Judkins AR (2011) p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors. J Neuropathol Exp Neurol 70:596–609

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Versteege I, Medjkane S, Rouillard D, Delattre O (2002) A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle. Oncogene 21:6403–6412

    Article  CAS  PubMed  Google Scholar 

  • Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O (1998) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203–206

    Article  CAS  PubMed  Google Scholar 

  • Warmuth-Metz M, Bison B, Dannemann-Stern E, Kortmann R, Rutkowski S, Pietsch T (2008) CT and MR imaging in atypical teratoid/rhabdoid tumors of the central nervous system. Neuroradiology 50:447–452

    Article  PubMed  Google Scholar 

  • Weeks DA, Beckwith JB, Mierau GW, Luckey DW (1989) Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms’ Tumor Study Pathology Center. Am J Surg Pathol 13:439–458

    Article  CAS  PubMed  Google Scholar 

  • Weinblatt M, Kochen J (1992) Rhabdoid tumor of the central nervous system. Med Pediatr Oncol 20:258

    Article  CAS  PubMed  Google Scholar 

  • Wetmore C, Boyett J, Li S, Lin T, Bendel A, Gajjar A, Orr BA (2015) Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children. Neuro-Oncology 17:882–888

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wilson BG, Roberts CW (2011) SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 11:481–492

    Article  CAS  PubMed  Google Scholar 

  • Wilson BG, Wang X, Shen X, Mckenna ES, Lemieux ME, Cho YJ, Koellhoffer EC, Pomeroy SL, Orkin SH, Roberts CW (2010) Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell 18:316–328

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Woehrer A, Slavc I, Waldhoer T, Heinzl H, Zielonke N, Czech T, Benesch M, Hainfellner JA, Haberler C (2010) Incidence of atypical teratoid/rhabdoid tumors in children: a population-based study by the Austrian Brain Tumor Registry, 1996–2006. Cancer 116:5725–5732

    Article  PubMed  Google Scholar 

  • Wohrle S, Weiss A, Ito M, Kauffmann A, Murakami M, Jagani Z, Thuery A, Bauer-Probst B, Reimann F, Stamm C, Pornon A, Romanet V, Guagnano V, Brummendorf T, Sellers WR, Hofmann F, Roberts CW, Graus Porta D (2013) Fibroblast growth factor receptors as novel therapeutic targets in SNF5-deleted malignant rhabdoid tumors. PLoS One 8:e77652

    Article  PubMed  PubMed Central  Google Scholar 

  • Zaky W, Dhall G, Ji L, Haley K, Allen J, Atlas M, Bertolone S, Cornelius A, Gardner S, Patel R, Pradhan K, Shen V, Thompson S, Torkildson J, Sposto R, Finlay JL (2014) Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience. Pediatr Blood Cancer 61:95–101

    Article  PubMed  Google Scholar 

  • Zhang ZK, Davies KP, Allen J, Zhu L, Pestell RG, Zagzag D, Kalpana GV (2002) Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Mol Cell Biol 22:5975–5988

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, King Abdulaziz Medical City, Jeddah, Saudi Arabia

    Eman Al Duhaiby M.B.B.S., F.R.C.P.C.

  2. Department of Radiation Oncology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-3678, USA

    Christopher Tinkle M.D., Ph.D.

  3. Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA

    Paul Aridgides M.D.

Authors
  1. Eman Al Duhaiby M.B.B.S., F.R.C.P.C.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher Tinkle M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul Aridgides M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Aridgides M.D. .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, St Jude Children’s Research Hospital, Memphis, Tennessee, USA

    Thomas E. Merchant

  2. Department of Radiation Oncology, University of Leipzig, Leipzig, Germany

    Rolf-Dieter Kortmann

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing Switzerland

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Al Duhaiby, E., Tinkle, C., Aridgides, P. (2018). Atypical Teratoid/Rhabdoid Tumor (AT/RT). In: Merchant, T., Kortmann, RD. (eds) Pediatric Radiation Oncology. Pediatric Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-43545-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43545-9_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43544-2

  • Online ISBN: 978-3-319-43545-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation